Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?

MOLECULAR INTERVENTIONS

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

1. NATIONAL CANCER INSTITUTE [ZIABC010026] Funding Source: NIH RePORTER